Update on Vaccine-Derived Poliovirus Outbreaks - Worldwide, January 2023-June 2024

被引:0
|
作者
Namageyo-Funa, Apophia [1 ]
Greene, Sharon A. [1 ]
Henderson, Elizabeth [2 ]
Traore, Mohamed A. [3 ]
Shaukat, Shahzad [3 ]
Bigouette, John Paul [1 ]
Jorba, Jaume [2 ]
Wiesen, Eric [1 ]
Bolu, Omotayo [1 ]
Diop, Ousmane M.
Burns, Cara C. [2 ]
Wassilak, Steven G. F. [1 ]
机构
[1] CDC, Ctr Global Hlth, Global Immunizat Div, Atlanta, GA 30329 USA
[2] CDC, Natl Ctr Immunizat & Resp Dis, Div Viral Dis, Atlanta, GA USA
[3] WHO, Polio Eradicat Dept, Geneva, Switzerland
来源
关键词
D O I
暂无
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
Circulating vaccine-derived polioviruses (cVDPVs) can emerge and lead to outbreaks of paralytic polio as well as asymptomatic transmission in communities with a high percentage of undervaccinated children. Using data from the World Health Organization Polio Information System and Global Polio Laboratory Network, this report describes global polio outbreaks due to cVDPVs during January 2023-June 2024 and updates previous reports. During the reporting period, 74 cVDPV outbreaks were detected in 39 countries or areas (countries), predominantly in Africa. Among these 74 cVDPV outbreaks, 47 (64%) were new outbreaks, detected in 30 (77%) of the 39 countries. Three countries reported cVDPV type 1 (cVDPV1) outbreaks and 38 countries reported cVDPV type 2 (cVDPV2) outbreaks; two of these countries reported cocirculating cVDPV1 and cVDPV2. In the 38 countries with cVDPV2 transmission, 70 distinct outbreaks were reported. In 15 countries, cVDPV transmission has lasted >1 year into 2024. In Nigeria and Somalia, both countries with security- compromised areas, persistent cVDPV2 transmission has spread to neighboring countries. Delayed implementation of outbreak response campaigns and low-quality campaigns have resulted in further international spread. Countries can control cVDPV outbreaks with timely allocation of resources to implement prompt, high-quality responses after outbreak confirmation. Stopping all cVDPV transmission requires effectively increasing population immunity by overcoming barriers to reaching children.
引用
收藏
页码:909 / 916
页数:8
相关论文
共 50 条
  • [41] Managing the risk of circulating vaccine-derived poliovirus during the endgame: oral poliovirus vaccine needs
    Radboud J. Duintjer Tebbens
    Kimberly M. Thompson
    BMC Infectious Diseases, 15
  • [42] Outbreaks of Circulating Vaccine-Derived Poliovirus in the World Health Organization Western Pacific Region, 2000-2021
    Kitamura, Kouichi
    Shimizu, Hiroyuki
    JAPANESE JOURNAL OF INFECTIOUS DISEASES, 2022, 75 (05) : 431 - 444
  • [43] Wild and vaccine-derived poliovirus circulation, and implications for polio eradication
    Lopalco, P. L.
    EPIDEMIOLOGY AND INFECTION, 2017, 145 (03): : 413 - 419
  • [44] Circulation of type 1 vaccine-derived poliovirus in the Philippines in 2001
    Shimizu, H
    Thorley, B
    Paladin, FJ
    Brussen, KA
    Stambos, V
    Yuen, L
    Utama, A
    Tano, Y
    Arita, M
    Yoshida, H
    Yoneyama, T
    Benegas, A
    Roesel, S
    Pallansch, M
    Kew, O
    Miyamura, T
    JOURNAL OF VIROLOGY, 2004, 78 (24) : 13512 - 13521
  • [45] Two Cases of Vaccine-Derived Poliovirus Infection in an Oncology Ward
    Schubert, Axel
    Boettcher, Sindy
    Eis-Huebinger, Anna M.
    NEW ENGLAND JOURNAL OF MEDICINE, 2016, 374 (13): : 1296 - 1298
  • [46] Preventing Vaccine-Derived Poliovirus Emergence during the Polio Endgame
    Pons-Salort, Margarita
    Burns, Cara C.
    Lyons, Hil
    Blake, Isobel M.
    Jafari, Hamid
    Oberste, M. Steven
    Kew, Olen M.
    Grassly, Nicholas C.
    PLOS PATHOGENS, 2016, 12 (07)
  • [47] Transmission of Imported Vaccine-Derived Poliovirus in an Undervaccinated Community in Minnesota
    Alexander, James P.
    Ehresmann, Kristen
    Seward, Jane
    Wax, Gary
    Harriman, Kathleen
    Fuller, Susan
    Cebelinski, Elizabeth A.
    Chen, Qi
    Jorba, Jaume
    Kew, Olen M.
    Pallansch, Mark A.
    Oberste, M. Steven
    Schleiss, Mark
    Davis, Jeffrey P.
    Warshawsky, Bryna
    Squires, Susan
    Hull, Harry F.
    JOURNAL OF INFECTIOUS DISEASES, 2009, 199 (03): : 391 - 397
  • [48] Evolution of circulating wild poliovirus and of vaccine-derived poliovirus in an immunodeficient patient: a unifying model
    Gavrilin, GV
    Cherkasova, EA
    Lipskaya, GY
    Kew, OM
    Agol, VI
    JOURNAL OF VIROLOGY, 2000, 74 (16) : 7381 - 7390
  • [49] Complete genome sequences of nine double recombinant vaccine-derived novel oral poliovirus type 2 genomes from Nigeria 2023-2024
    Castro, Christina J.
    Oderinde, Bamidele Soji
    Poston, Katherine D.
    Mawashi, Kabir Yusuf
    Bullard, Kelley
    Akinola, Monilade
    Meade, Caeden
    Liu, Hongmei
    Hu, Fang
    Bullows, James E.
    Gonzalez, Zachary
    Pang, Hong
    Sarris, Sarah
    Agha, Chadi
    Dybdahl-Sissoko, Naomi
    Perry, Daniel B.
    Mcduffie, Larin
    Henderson, Elizabeth
    Burns, Cara C.
    Jorba, Jaume
    Baba, Marycelin
    MICROBIOLOGY RESOURCE ANNOUNCEMENTS, 2024, 13 (12)
  • [50] Circulating vaccine-derived poliovirus type 2 outbreak 2024: the current public health concerns and management strategies
    Rajbongshi, Anjon
    Malaker, Suprety
    Shandhi, Shoubeho S.
    Islam, Md. R.
    Dewan, Syed M. R.
    INTERNATIONAL JOURNAL OF SURGERY OPEN, 2024, 62 (04) : 460 - 463